ATSENA THERAPEUTICS
Atsena Therapeutics is a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness. They have a pipeline of clinical and preclinical assets powered by an adeno-associated virus (AAV) technology platform that is tailored to overcome the hurdles presented by inherited retinal disease.
Atsena’s approach is guided by the specific needs of each patient’s condition. Their dedication to their patients is the focus of their research.
Designed while employed at Fassino/Design.